Skip to main content

Month: April 2023

G MEDICAL UPDATES ON PATIENT ENROLLMENT GROWTH FOR ITS HOME MONITORING SERVICES OF 194% FROM JANUARY THROUGH APRIL 2023, AS COMPARED TO THE SAME PERIOD IN 2022

Rehovot, Israel, April 18, 2023 (GLOBE NEWSWIRE) — G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company” or “G Medical”), a global leader in next-generation mobile health (mHealth) and digital health, is excited to report that patient enrollment has grown in its home monitoring services by 194% between January and April of 2023, as compared to the same period last year. The increase is due to growing demand for homecare monitoring. As previously announced, in the first quarter of 2023, G Medical signed an agreement with AdventHealth of Central Florida (“AdventHealth”), an operator of 20 hospitals and emergency rooms. AdventHealth experiences on average 5.7 million patient visits per year. G Medical also recently signed an agreement with MiCare Path to integrate MiCare Path’s software platform and visualization...

Continue reading

Immuneering Announces $30 Million Underwritten Offering

CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX) (“Immuneering”), a clinical-stage oncology company developing medicines for broad populations of cancer patients with an initial aim to develop a universal-RAS therapy, today announced the pricing of its underwritten offering of 2,727,273 shares of its Class A common stock at an offering price of $11.00 per share. The gross proceeds from the offering are expected be $30 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Immuneering. All shares in the offering will be offered by Immuneering. Jefferies, TD Cowen and Guggenheim Securities are acting as the joint book-running managers for the offering. Immuneering intends to use the net proceeds of the offering to advance the preclinical...

Continue reading

News from INVL Technology managed companies: NRD Cyber Security‘s income grew by 13% giving an increased gross profit of 27% in 2022

NRD Cyber Security, a cybersecurity consulting and technology implementation company, increased its revenue by 13% to €6.08 million in 2022, compared to €5.37 million in 2021. The company’s gross profit in 2022 was €2.98 million, an increase of 27% on the previous year. Operating profits stood at €0.56 million, down 8% from 2021. NRD Cyber Security took over operational control of NRD Bangladesh Ltd at the end of 2021. NRD Cyber Security’s sales revenues in foreign markets amounted to €1.33 million in 2022, which was a 50% on the previous year largely due to sales of NRD Cyber Security’s consulting services and its own brand Natrix and CyberSet products in Egypt, Malawi, Bahamas, and other markets. Sales revenue from the Lithuanian market grew by 6% on the previous year to €4.75 million. In 2022, the company had projects...

Continue reading

Adagene Presents Clinical Data for Anti-CTLA-4 SAFEbody® ADG126 Reinforcing Best-in-Class Safety Profile at Repeat Doses and Showing Early Efficacy Profile in Advanced/Metastatic Solid Tumors

– Results of dose escalation portion from phase 1b/2 trials of ADG126 in combination with anti-PD-1 therapies, including confirmed clinical responses, pave way for dose expansion in specific tumors – – Tumor shrinkage and prolonged stable disease observed in ‘cold’ tumors such as MSS CRC – – Robust safety profile allows repeat dosing, sustained target engagement and Treg depletion to maximize long-term clinical benefit – SAN DIEGO and SUZHOU, China, April 18, 2023 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies, today announced interim results from its combination dose escalation studies of the masked, anti-CTLA-4 SAFEbody, ADG126, presented at the AACR Annual Meeting in Orlando, Florida, April 14-19,...

Continue reading

Edible Garden Demonstrates Leadership Position and Commitment to Food Safety Including Food Safety Research Study Collaboration with Auburn University

BELVIDERE, NJ, April 18, 2023 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic and sustainable produce and products, today provided an update on ongoing initiatives the Company has taken to establish its leadership and reinforce its commitment to food safety. Mr. Jim Kras, Chief Executive Officer of Edible Garden, commented, “Consumers demand food that is not only nutritious and sustainably produced but, most importantly, safe to consume. Recent produce recalls have only reinforced these concerns. While no company is immune to potential risks, Edible Garden has consistently positioned itself at the forefront of the industry. Embodying our ‘Simply Local…Simply Fresh™’ mission,...

Continue reading

BioSyent to Present at 2023 Bloom Burton & Co. Healthcare Investor Conference

MISSISSAUGA, Ontario, April 18, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2023 Bloom Burton & Co. Healthcare Investor Conference. The conference will be held in Toronto at the Metro Toronto Convention Centre (North Building) on Tuesday, April 25 and Wednesday, April 26, 2023 between 8:30am and 4:30pm ET. Mr. René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activities on Tuesday, April 25 at 2:00pm. Mr. Goehrum will also be available to meet with investors on a one-on-one basis during the conference. These one-on-one meetings can be requested by attendees through the conference portal online: https://www.meetmax.com/sched/event_91703/investor_login.html?event_id=91703. About...

Continue reading

Nexstim Plc: Managers’ Transactions, Forss

Company Announcement, Helsinki, 18 April 2023 at 4:15 PM (EEST) Nexstim Plc: Managers’ Transactions, Forss Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) announces managers’ transactions as follows: Person subject to the notification requirementName: Martin ForssPosition: Member of the Board/Deputy memberIssuer: Nexstim OyjLEI: 743700S7ZI0LNMHZ6Y27Notification type: INITIAL NOTIFICATIONReference number: 28741/5/4____________________________________________ Transaction date: 2023-04-17Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000506811Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE(X) Linked to stock option programme Transaction details(1): Volume: 2293 Unit price: 0 EUR Aggregated transactions (1):Volume: 2293 Volume weighted average price: 0 EUR Further information...

Continue reading

Nexstim Plc: Managers’ Transactions, Weckroth

Company Announcement, Helsinki, 18 April 2023 at 4:10 PM (EEST) Nexstim Plc: Managers’ Transactions, Weckroth Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) announces managers’ transactions as follows: Person subject to the notification requirementName: Tero WeckrothPosition: Member of the Board/Deputy memberIssuer: Nexstim OyjLEI: 743700S7ZI0LNMHZ6Y27Notification type: INITIAL NOTIFICATIONReference number: 28742/4/4____________________________________________ Transaction date: 2023-04-17Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000506811Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE(X) Linked to stock option programme Transaction details(1): Volume: 2448 Unit price: 0 EUR Aggregated transactions (1):Volume: 2448 Volume weighted average price: 0 EUR Further information...

Continue reading

AGBA Group Holding Limited (NASDAQ: ‘AGBA’) announces Share Repurchase Program

HONG KONG, April 18, 2023 (GLOBE NEWSWIRE) — NASDAQ-listed, AGBA Group Holding Limited (“AGBA”), the leading one- stop financial supermarket in Hong Kong, today announced that its Board of Directors approved a share repurchase program with authorization to purchase up to 1,000,000 ordinary shares of AGBA with a maximum of $10,000,000 to be expended.  The share repurchase program reflects AGBA’s commitment to returning value to its shareholders, while maintaining the financial flexibility to invest in growth opportunities. The program also reflects the company’s confidence in its future prospects. Wing-Fai Ng, Group President, AGBA Group Holding Limited said, “Creating and defending shareholder value is a core focus of AGBA.  Our scale, combined with the strength of our business and the significant opportunities arising from China’s...

Continue reading

Iveda Partners with Evergreen Aviation, Revolutionizing the Unmanned Aerial Vehicle Industry

Military grade drones will provide government groups with real-time surveillance capabilities for enhanced security MESA, Ariz., April 18, 2023 (GLOBE NEWSWIRE) — Iveda® (NASDAQ:IVDA), the global solution for cloud-based AI video and sensor technologies, today announces a partnership with aircraft maintenance solutions provider, Evergreen Aviation Technologies Corp. (EGAT) to bring cutting-edge Unmanned Aerial Vehicles (UAVs) to the global market. Through this collaboration, Iveda will also gain worldwide rights to promote and sell military grade drones that can fly at 10,000 to 30,000 feet, vastly expanding EGAT’s reach cross-border.  Leveraging each company’s technological developments, Iveda and EGAT together will provide governments and military groups around the world access to state-of-the-art smart drones, effectively enhancing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.